AB
CRBP icon

Amalgamated Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Amalgamated Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-352
Closed -$2K – 3037
2025
Q1 		$2K Hold
352
– – ﹤0.01% 2832
2024
Q4 		$4K Hold
352
– – ﹤0.01% 2777
2024
Q3 		$7K Hold
352
– – ﹤0.01% 2605
2024
Q2 		$16K Buy
+352
New +$14.8K ﹤0.01% 2209
2021
Q2 		– Sell
-387
Closed -$23K – 2179
2021
Q1 		$23K Hold
387
– – ﹤0.01% 1594
2020
Q4 		$15K Hold
387
– – ﹤0.01% 1584
2020
Q3 		$21K Buy
387
+35
+10% +$6.34K ﹤0.01% 1484
2020
Q2 		$89K Sell
352
-5
-1% -$1.01K ﹤0.01% 1409
2020
Q1 		$56K Sell
357
-18
-5% -$3.04K ﹤0.01% 1555
2019
Q4 		$61K Buy
375
+21
+6% +$3.1K ﹤0.01% 1777
2019
Q3 		$52K Sell
354
-3
-0.8% -$523 ﹤0.01% 1708
2019
Q2 		$74K Buy
+357
New +$76.4K ﹤0.01% 1719

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Amalgamated Bank's CRBP Position: Q2 2025 in Review

Amalgamated Bank sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 352 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in CRBP in Q2 2019 and held it in 12 quarters. The position peaked at $89K in Q2 2020. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Amalgamated Bank reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 352 Corbus Pharmaceuticals shares in Q2 2025, an estimated $2K.
  • Amalgamated Bank first reported a position in Corbus Pharmaceuticals in Q2 2019 and held it in 12 quarters.
  • Amalgamated Bank's Corbus Pharmaceuticals position peaked at $89K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.